Drug Profile
Research programme: gastric ulcer therapeutic - Daewoong Pharmaceutical
Alternative Names: Anti-ulcerant - Daewoong; DWJ 206Latest Information Update: 28 Mar 2023
Price :
$50
*
At a glance
- Originator Daewoong Pharmaceutical
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Gastric ulcer
Most Recent Events
- 28 Mar 2023 Discontinued - Preclinical for Gastric ulcer in South Korea (unspecified route)
- 28 Apr 2018 No recent reports of development identified for preclinical development in Gastric-ulcer in South Korea
- 18 Mar 2014 Preclinical trials in Gastric ulcer in South Korea (unspecified route)